Dow Up 1.31% Nasdaq Up 2.40%

ImmunoGen, Inc. (IMGN)

-NasdaqGS
8.84 Down 0.62(6.55%) 4:00PM EDT
Prev Close:9.46
Open:9.56
Bid:8.65 x 100
Ask:N/A
1y Target Est:15.27
Beta:2.08
Next Earnings Date:24-Oct-14IMGN Earnings announcement
Day's Range:8.57 - 9.71
52wk Range:7.70 - 18.19
Volume:1,622,590
Avg Vol (3m):1,004,650
Market Cap:759.42M
P/E (ttm):N/A
EPS (ttm):-0.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IMGNDown 6.55%759.42M
PFEUp 1.25%179.32B
RHHBYUp 1.51%247.27B
SGENUp 0.17%4.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.73
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback